Merck is the first drug manufacturer to announce it is issuing refunds to 340B providers in 2024.

Merck Loosens 340B Contract Pharmacy Restrictions in Two States as Louisiana Law Takes Effect

Drug manufacturer Merck recently loosened its 340B program contract pharmacy restrictions in Louisiana and Arkansas just before Louisiana’s law protecting [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at